Patent details
EP2218461 Title: CD40 antibody formulation and methods
Basic Information
- Publication number:
- EP2218461
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP101627875
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CD40 antibody formulation and methods
- French Title of Invention:
- Formulation d'anticorps CD40 et méthodes
- German Title of Invention:
- CD40-Antikörper-Formulierung und Verfahren
- SPC Number:
Dates
- Filing date:
- 09/12/2004
- Grant date:
- 20/04/2016
- EP Publication Date:
- 20/04/2016
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/08/2010
- EP B1 Publication Date:
- 20/04/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/12/2016
- Expiration date:
- 09/12/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 09/12/2004
- Name:
- Pfizer Products Inc.
- Address:
- Eastern Point Road, Groton, CT 06340, United States (US)
Inventor
1
- Name:
- Gladue Ronald, Paul
- Address:
- United States (US)
2
- Name:
- Cusmano John, Daniel
- Address:
- United States (US)
3
- Name:
- Bedian Vahe
- Address:
- United States (US)
Priority
- Priority Number:
- 531639 P
- Priority Date:
- 22/12/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 39/395;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|